Annual SGA
$58.09 M
+$15.70 M+37.03%
December 31, 2023
Summary
- As of February 22, 2025, CRNX annual SGA is $58.09 million, with the most recent change of +$15.70 million (+37.03%) on December 31, 2023.
- During the last 3 years, CRNX annual SGA has risen by +$40.07 million (+222.28%).
- CRNX annual SGA is now at all-time high.
Performance
CRNX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$25.89 M
+$1.05 M+4.24%
September 30, 2024
Summary
- As of February 22, 2025, CRNX quarterly SGA is $25.89 million, with the most recent change of +$1.05 million (+4.24%) on September 30, 2024.
- Over the past year, CRNX quarterly SGA has increased by +$10.41 million (+67.22%).
- CRNX quarterly SGA is now at all-time high.
Performance
CRNX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.04 B
-$277.91 M-10.06%
September 30, 2024
Summary
- As of February 22, 2025, CRNX TTM SGA is -$3.04 billion, with the most recent change of -$277.91 million (-10.06%) on September 30, 2024.
- Over the past year, CRNX TTM SGA has dropped by -$3.09 billion (-5914.76%).
- CRNX TTM SGA is now -18593.74% below its all-time high of -$16.27 million.
Performance
CRNX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CRNX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.0% | +67.2% | -5914.8% |
| 3 y3 years | +222.3% | +67.2% | -5914.8% |
| 5 y5 years | +772.4% | +67.2% | -5914.8% |
CRNX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.9% | at high | +251.7% | -228.1% | at low |
| 5 y | 5-year | at high | +329.7% | at high | +663.3% | -947.5% | at low |
| alltime | all time | at high | +3689.6% | at high | +6505.1% | <-9999.0% | at low |
Crinetics Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.89 M(+4.2%) | $88.64 M(+13.3%) |
| Jun 2024 | - | $24.84 M(+19.3%) | $78.23 M(+17.2%) |
| Mar 2024 | - | $20.83 M(+22.0%) | $66.73 M(+14.9%) |
| Dec 2023 | $58.09 M(+37.0%) | $17.08 M(+10.3%) | $58.09 M(+11.1%) |
| Sep 2023 | - | $15.48 M(+16.0%) | $52.29 M(+7.3%) |
| Jun 2023 | - | $13.34 M(+9.5%) | $48.73 M(+6.2%) |
| Mar 2023 | - | $12.19 M(+8.1%) | $45.88 M(+8.2%) |
| Dec 2022 | $42.39 M(+72.9%) | $11.27 M(-5.5%) | $42.39 M(+10.2%) |
| Sep 2022 | - | $11.93 M(+13.7%) | $38.48 M(+17.4%) |
| Jun 2022 | - | $10.49 M(+20.5%) | $32.78 M(+17.5%) |
| Mar 2022 | - | $8.71 M(+18.3%) | $27.90 M(+13.7%) |
| Dec 2021 | $24.52 M(+36.1%) | $7.36 M(+18.2%) | $24.52 M(+10.9%) |
| Sep 2021 | - | $6.23 M(+11.2%) | $22.12 M(+7.1%) |
| Jun 2021 | - | $5.60 M(+5.0%) | $20.65 M(+6.6%) |
| Mar 2021 | - | $5.33 M(+7.5%) | $19.37 M(+7.5%) |
| Dec 2020 | $18.03 M | $4.96 M(+4.4%) | $18.03 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $4.75 M(+9.9%) | $16.46 M(+5.4%) |
| Jun 2020 | - | $4.32 M(+8.3%) | $15.62 M(+8.8%) |
| Mar 2020 | - | $3.99 M(+17.7%) | $14.35 M(+6.2%) |
| Dec 2019 | $13.52 M(+103.0%) | $3.39 M(-13.3%) | $13.52 M(+6.5%) |
| Sep 2019 | - | $3.91 M(+27.8%) | $12.69 M(+20.7%) |
| Jun 2019 | - | $3.06 M(-3.0%) | $10.51 M(+22.7%) |
| Mar 2019 | - | $3.16 M(+23.2%) | $8.57 M(+28.7%) |
| Dec 2018 | $6.66 M(+243.4%) | $2.56 M(+47.9%) | $6.66 M(+45.9%) |
| Sep 2018 | - | $1.73 M(+54.9%) | $4.57 M(+37.3%) |
| Jun 2018 | - | $1.12 M(-10.4%) | $3.32 M(+27.9%) |
| Mar 2018 | - | $1.25 M(+167.2%) | $2.60 M(+34.0%) |
| Dec 2017 | $1.94 M(+26.5%) | $467.00 K(-4.9%) | $1.94 M(+31.7%) |
| Sep 2017 | - | $491.00 K(+25.3%) | $1.47 M(+50.1%) |
| Jun 2017 | - | $392.00 K(-33.4%) | $981.00 K(+66.6%) |
| Mar 2017 | - | $589.00 K | $589.00 K |
| Dec 2016 | $1.53 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual SGA year-on-year change?
- What is Crinetics Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly SGA year-on-year change?
- What is Crinetics Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM SGA year-on-year change?
What is Crinetics Pharmaceuticals annual SGA?
The current annual SGA of CRNX is $58.09 M
What is the all time high annual SGA for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual SGA is $58.09 M
What is Crinetics Pharmaceuticals annual SGA year-on-year change?
Over the past year, CRNX annual SGA has changed by +$15.70 M (+37.03%)
What is Crinetics Pharmaceuticals quarterly SGA?
The current quarterly SGA of CRNX is $25.89 M
What is the all time high quarterly SGA for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly SGA is $25.89 M
What is Crinetics Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, CRNX quarterly SGA has changed by +$10.41 M (+67.22%)
What is Crinetics Pharmaceuticals TTM SGA?
The current TTM SGA of CRNX is -$3.04 B
What is the all time high TTM SGA for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM SGA is -$16.27 M
What is Crinetics Pharmaceuticals TTM SGA year-on-year change?
Over the past year, CRNX TTM SGA has changed by -$3.09 B (-5914.76%)